AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2015

Jul 1, 2015

32870_dirs_2015-07-01_e657e2c3-f1f0-4508-9237-8413b220b7ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-06-29

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-29	Common Stock	S	4923	$32.76	Disposed	23577	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.54 to $32.965, inclusive.